Key takeaways:
Anemia is a health condition caused by not having enough red blood cells.
Procrit (epoetin alfa) is a biologic medication that's injected under your skin or into your vein. It's FDA-approved to treat different types of anemia.
Procrit has a number of possible side effects, and some of them can be serious. Your healthcare provider can help you choose the right medication for you based on your other health conditions, current lab results, and insurance status.
If you or a loved one live with anemia, you’re well aware how bothersome it can be. You may often feel tired or weak, and there may be times when you feel irritable, cold, or dizzy. These types of anemia symptoms are often attributable to one key factor — not having enough red blood cells in your body.
Red blood cells carry oxygen to tissues and organs throughout your body, so when there’s not enough of them, many parts of your body are affected. Because of this, treatments for anemia are usually aimed at boosting the number of red blood cells in your body.
So, if you or someone you know has anemia, you may be curious about what your treatment options are. One medication used to treat different types of anemia is Procrit (epoetin alfa). But there’s a lot to know about the medication, and it can understandably get confusing.
Here, we'll talk about Procrit — what it is, how it works, and how much it costs.
Procrit is an injectable biologic medication that's FDA-approved to treat different types of anemia. Biologics are medications that are made from natural sources, like sugars, proteins, and tissues. Procrit can be injected into a vein or under your skin.
Procrit may be used to treat anemia if it is caused by:
Chronic kidney disease (CKD) (with or without dialysis)
Zidovudine, a medication that treats HIV
In addition to these, Procrit can also help prevent complications from blood loss caused by elective surgeries that aren’t related to your heart or blood vessels
Procrit is an erythropoietin stimulating agent (ESA). It tells your body to make more red blood cells to treat anemia. It’s used to help avoid the need for red blood cell transfusions (donated blood given into your vein).
ESAs work similarly to a naturally-occurring hormone in our body called erythropoietin (EPO). EPO sends a signal to your body to make more red blood cells. This also helps raise your hemoglobin, which is a protein in red blood cells that helps carry oxygen to tissues and organs throughout your body.
However, Procrit doesn’t work right away. It usually takes 2 to 6 weeks for your body to make new red blood cells. Your healthcare provider will monitor your hemoglobin levels and may change your Procrit dose to make sure you reach your goal.
Procrit is given as a subcutaneous (under the skin) or intravenous (into the vein) injection. It’s available in two forms: a single-dose or multiple-use vial. Your healthcare provider may give it to you, or you could be instructed to use it at home.
The recommended starting dose for CKD is 50 to 100 units per kilogram of body weight, 3 times weekly. After starting Procrit, your healthcare provider will likely monitor your hemoglobin levels weekly until your level is stable. Your provider may also adjust your dose once every 4 weeks if needed.
But as discussed, Procrit treats different types of anemia. Your dose will depend on the type of anemia you have. It can be given daily, 3 times a week, or once a week. You should always take Procrit exactly as your healthcare provider tells you to.
Like all medications, Procrit can cause some side effects. Some are common and manageable, but serious side effects are also possible. You should tell your healthcare provider about any side effects that you experience.
Specific side effects vary depending on what you’re using Procrit to treat. But, common side effects of Procrit can include:
Irritation (like redness, pain, swelling) where the medication was injected
Joint or muscle pain
Fever
Dizziness
Headache
Cough
Nausea and vomiting
Procrit has a few boxed warnings — the most serious type of warning the FDA can give a medication about risks and side effects.
If you have cancer and are receiving Procrit, it may make your tumor grow faster, and you may die sooner. Because of this, oncologists won’t use Procrit in people with cancer when the goal of treatment is to cure the cancer.
For other people who take Procrit, serious heart conditions such as heart failure, heart attack, and stroke are possible. This risk is higher for people with heart-related conditions and higher hemoglobin levels. To lower this risk, your healthcare provider will regularly check your labs and use the lowest Procrit dose necessary.
Blood clots may also happen while taking Procrit. If you need surgery, it's important to talk with your healthcare provider about whether or not you need to take a blood thinner to help prevent blood clots during or after surgery. Call your healthcare provider immediately or go to the emergency room if you have any of the following symptoms of a blood clot:
Trouble breathing, chest pain, or sweating
Trouble speaking, seizures, or weakness
Pain, swelling, or warmth in your arm or leg
Your dialysis access stops working
These aren’t the only serious possible side effects. If you’re currently receiving Procrit or have been told you may need it in the future, it’s important to talk with your healthcare provider about all of the risks that are possible.
Procrit is quite effective when treating anemia for people with CKD.
One study found that Procrit can help raise hemoglobin levels after 4 weeks in people with CKD who aren’t on dialysis. The same study also showed that people taking Procrit had a significant improvement in energy levels and ability to do work than those taking placebo (an injection with no medication in it).
In another study, Procrit also raised hemoglobin for people with CKD on dialysis. After 2 months, people receiving Procrit experienced significant improvements in exercise tolerance and physical function compared to placebo.
But, as mentioned, Procrit can treat anemia due to other causes. Procrit has also been shown to effectively treat and reduce the symptoms of anemia due to chemotherapy and zidovudine. It can also effectively help prevent complications from blood loss caused by elective surgeries.
Procrit is expensive, especially if it’s not covered by insurance. For example, the list price per month for Procrit was over $4,800 in 2020. Since the dose for Procrit varies depending on your body weight and medical condition, specific costs vary for everyone. But there are always ways you can save.
If you have Medicare, Part B may pay the majority of the costs for Procrit. Part B covers medications you receive in a healthcare provider's office or clinic. Most of the time, you can expect to pay 20% of the Medicare-approved amount for the Part B-covered medications after you've paid your Part B deductible. For 2022, your Medicare Part B deductible is $233.
If you have Medicaid, you may find your medication is covered depending on your local program. Procrit may be free or a low cost to you. Keep in mind the federal government sets the guidelines, but each state runs its own Medicaid program. Because of this, your eligibility and potential cost varies from state to state.
If you don't have insurance, if your medicine isn't covered by insurance, or if you have Medicare and can't pay for your Procrit, the Johnson & Johnson Patient Assistance Foundation may be able to help you get Procrit for no cost. For more information, call 1-800-652-6227 or apply online.
Other financial assistance programs are also available. For example, if you have Medicare and meet certain income requirements, you may be able to receive financial assistance from the HealthWell Foundation or the federal government's Extra Help program.
You and your healthcare provider will decide what anemia treatment is best for you based on what type of anemia you have. Your healthcare provider will likely consider other health conditions, current lab results, and insurance status.
But if your healthcare provider believes you need an ESA to treat anemia, other options include:
Epogen (epoetin alfa)
Retacrit (epoetin alfa)
Aranesp (darbepoetin alfa)
Mircera (methoxy polyethylene glycol-epoetin beta)
Retacrit is biosimilar to both Procrit and Epogen. A biosimilar is a biologic medication that is highly similar to an FDA-approved reference biologic medication. Biosimilars have similar safety and effectiveness and tend to be less expensive than their reference biologic.
But, ultimately, the best medication for different types of anemia is different for every person. Your healthcare provider can help choose the best treatment for you.
Procrit is an injectable ESA used to treat different types of anemia. Your dose will depend on your body weight and the cause of your anemia. It has a number of possible side effects, some of which can be serious. Be sure to discuss any questions or concerns with your healthcare provider.
American Red Cross. (n.d.). Blood transfusion process.
American Red Cross. (n.d.). Red blood cells and why they are important.
Centers for Disease Control and Prevention. (2021). Types of stroke.
Food and Drug Administration. (n.d.). Biological product definitions.
HealthWell Foundation. (n.d.). Anemia associated with chronic renal insufficiency/failure.
Janssen Products, LP. (2020). Procrit [package insert].
Johnson & Johnson Patient Assistance Foundation, Inc. (n.d.). Johnson & Johnson Patient Assistance Foundation.
Johnson & Johnson Patient Assistance Foundation, Inc. (2022). Patient assistance program application.
Medicare.gov. (n.d.). Part B costs.
Medicare.gov. (n.d.). Prescription drugs (outpatient).
MedlinePlus. (2022). Blood clots.
Muirhead, N., et al. (2011). Dialysis patients treated with epoetin α show improved exercise tolerance and physical function: A new analysis of the Canadian erythropoietin study group trial. Hemodialysis International.
National Cancer Institute. (n.d.). Hemoglobin.
National Cancer Institute. (2015). Chemotherapy to treat cancer.
National Heart, Lung, and Blood Institute. (n.d.). Anemia.
National Kidney Foundation. (n.d.). Dialysis.
National Kidney Foundation. (2015). Hemodialysis access.
Procrit. (2018). Chemotherapy-induced anemia (CIA).
Procrit. (2018). Chronic kidney disease (CKD).
Procrit. (2018). Elective surgery.
Procrit. (2018). Zidovudine-induced anemia in patients with HIV infection.
Schoener, B., et al. (2021). Erythropoietin stimulating agents. StatPearls.
The US Recombinant Human Erythropoietin Predialysis Study Group. (1991). Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. American Journal of Kidney Diseases.
Turner, J., et al. (2022). Anemia. StatPearls.
U.S. Social Security Administration. (n.d.). Extra help with Medicare prescription drug plan costs.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.